Frontiers in Genetics-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向：肿瘤;纯生信;基因 经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2110208, encodeId=c01b2110208a0, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投了一篇生信加大量验证的，当时想不开选了国人编辑，果然对国人最狠的就是同胞，直接痛下杀手, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ef12114541, createdName=1891f95b28m, createdTime=Sat Jan 14 16:06:49 CST 2023, time=2023-01-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1235117, encodeId=a67a123511ebb, content=偏重的研究方向：基因 经验分享：一个审稿人拒绝，另一个让小修并且4 4 4 4分，这种是不是修回去也被拒，正常不应该至少两个审稿人同意才可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83675615943, createdName=ms5000001280844911, createdTime=Wed Jul 27 17:53:30 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105246, encodeId=8cb42105246d8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：阿尔兹海默症 经验分享：投稿一篇纯生信，单基因 六月份投的，很快邀请了一个审稿人，审稿人也很快回复了，提了几个小问题 之后拖了俩月问让推荐审稿人，后来第二个是自己推荐的 前几天accept了，总体来说还是好中的，毕竟我只是个本科菜鸡，希望别预警, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b47b6157206, createdName=ms7000000033418611, createdTime=Sat Dec 10 15:19:57 CST 2022, time=2022-12-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=997387, encodeId=339499e3872c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基因 ; 分子生物学 经验分享：请问有最近5月或者6月投的送外审的嘛？我半个月了，还在编辑手里。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66555211329, createdName=1475e5bfm86暂无昵称, createdTime=Thu Jul 08 06:00:59 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057883, encodeId=c35f105e8835b, content=请问8月9月投稿的同学们，最近从 Editorial assignment到Independent review的时间长吗? 我的20天了还没有动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3a05219761, createdName=黄悦子, createdTime=Tue Oct 05 12:59:36 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208985, encodeId=044d1208985fe, content=从frontiers in pharmacology转投的这个杂志。不知道要多长时间才能到编辑手里呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26f5278477, createdName=14839f7dm82(暂无昵称), createdTime=Wed Apr 06 14:45:58 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107795, encodeId=6694210e7955e, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：wos里面收录的文章大家看看时间把从3 4 月份以后就没收录进去了。而我的另外一篇比我genetics 发表时间晚一个月的 in oncology 早收录进去了。小心要出幺蛾子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0abe2931453, createdName=chobit39, createdTime=Wed Dec 28 11:12:15 CST 2022, time=2022-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108229, encodeId=90072108229dd, content=请问大家都有几个审稿人啊，我直接有五个，而且都在规定时间内提了意见，我何德何能啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc9f8128107, createdName=好运常伴, createdTime=Sat Dec 31 00:55:37 CST 2022, time=2022-12-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2106370, encodeId=a23f21063e0ca, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：纯生信 经验分享：请问如何修改作者信息？投稿时作者名字写重了，现在系统里没法修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dd52967601, createdName=214751809, createdTime=Fri Dec 16 17:32:15 CST 2022, time=2022-12-16, status=1, ipAttribution=天津)]

2023-02-26 少年宁来自浙江省

偏重的研究方向：肿瘤;纯生信;基因
经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！

57 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向：肿瘤;纯生信;基因 经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2110208, encodeId=c01b2110208a0, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投了一篇生信加大量验证的，当时想不开选了国人编辑，果然对国人最狠的就是同胞，直接痛下杀手, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ef12114541, createdName=1891f95b28m, createdTime=Sat Jan 14 16:06:49 CST 2023, time=2023-01-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1235117, encodeId=a67a123511ebb, content=偏重的研究方向：基因 经验分享：一个审稿人拒绝，另一个让小修并且4 4 4 4分，这种是不是修回去也被拒，正常不应该至少两个审稿人同意才可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83675615943, createdName=ms5000001280844911, createdTime=Wed Jul 27 17:53:30 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105246, encodeId=8cb42105246d8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：阿尔兹海默症 经验分享：投稿一篇纯生信，单基因 六月份投的，很快邀请了一个审稿人，审稿人也很快回复了，提了几个小问题 之后拖了俩月问让推荐审稿人，后来第二个是自己推荐的 前几天accept了，总体来说还是好中的，毕竟我只是个本科菜鸡，希望别预警, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b47b6157206, createdName=ms7000000033418611, createdTime=Sat Dec 10 15:19:57 CST 2022, time=2022-12-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=997387, encodeId=339499e3872c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基因 ; 分子生物学 经验分享：请问有最近5月或者6月投的送外审的嘛？我半个月了，还在编辑手里。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66555211329, createdName=1475e5bfm86暂无昵称, createdTime=Thu Jul 08 06:00:59 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057883, encodeId=c35f105e8835b, content=请问8月9月投稿的同学们，最近从 Editorial assignment到Independent review的时间长吗? 我的20天了还没有动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3a05219761, createdName=黄悦子, createdTime=Tue Oct 05 12:59:36 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208985, encodeId=044d1208985fe, content=从frontiers in pharmacology转投的这个杂志。不知道要多长时间才能到编辑手里呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26f5278477, createdName=14839f7dm82(暂无昵称), createdTime=Wed Apr 06 14:45:58 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107795, encodeId=6694210e7955e, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：wos里面收录的文章大家看看时间把从3 4 月份以后就没收录进去了。而我的另外一篇比我genetics 发表时间晚一个月的 in oncology 早收录进去了。小心要出幺蛾子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0abe2931453, createdName=chobit39, createdTime=Wed Dec 28 11:12:15 CST 2022, time=2022-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108229, encodeId=90072108229dd, content=请问大家都有几个审稿人啊，我直接有五个，而且都在规定时间内提了意见，我何德何能啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc9f8128107, createdName=好运常伴, createdTime=Sat Dec 31 00:55:37 CST 2022, time=2022-12-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2106370, encodeId=a23f21063e0ca, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：纯生信 经验分享：请问如何修改作者信息？投稿时作者名字写重了，现在系统里没法修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dd52967601, createdName=214751809, createdTime=Fri Dec 16 17:32:15 CST 2022, time=2022-12-16, status=1, ipAttribution=天津)]

2023-01-14 1891f95b28m 来自江西省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：投了一篇生信加大量验证的，当时想不开选了国人编辑，果然对国人最狠的就是同胞，直接痛下杀手

45 0

[GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向：肿瘤;纯生信;基因 经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2110208, encodeId=c01b2110208a0, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投了一篇生信加大量验证的，当时想不开选了国人编辑，果然对国人最狠的就是同胞，直接痛下杀手, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ef12114541, createdName=1891f95b28m, createdTime=Sat Jan 14 16:06:49 CST 2023, time=2023-01-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1235117, encodeId=a67a123511ebb, content=偏重的研究方向：基因 经验分享：一个审稿人拒绝，另一个让小修并且4 4 4 4分，这种是不是修回去也被拒，正常不应该至少两个审稿人同意才可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83675615943, createdName=ms5000001280844911, createdTime=Wed Jul 27 17:53:30 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105246, encodeId=8cb42105246d8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：阿尔兹海默症 经验分享：投稿一篇纯生信，单基因 六月份投的，很快邀请了一个审稿人，审稿人也很快回复了，提了几个小问题 之后拖了俩月问让推荐审稿人，后来第二个是自己推荐的 前几天accept了，总体来说还是好中的，毕竟我只是个本科菜鸡，希望别预警, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b47b6157206, createdName=ms7000000033418611, createdTime=Sat Dec 10 15:19:57 CST 2022, time=2022-12-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=997387, encodeId=339499e3872c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基因 ; 分子生物学 经验分享：请问有最近5月或者6月投的送外审的嘛？我半个月了，还在编辑手里。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66555211329, createdName=1475e5bfm86暂无昵称, createdTime=Thu Jul 08 06:00:59 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057883, encodeId=c35f105e8835b, content=请问8月9月投稿的同学们，最近从 Editorial assignment到Independent review的时间长吗? 我的20天了还没有动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3a05219761, createdName=黄悦子, createdTime=Tue Oct 05 12:59:36 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208985, encodeId=044d1208985fe, content=从frontiers in pharmacology转投的这个杂志。不知道要多长时间才能到编辑手里呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26f5278477, createdName=14839f7dm82(暂无昵称), createdTime=Wed Apr 06 14:45:58 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107795, encodeId=6694210e7955e, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：wos里面收录的文章大家看看时间把从3 4 月份以后就没收录进去了。而我的另外一篇比我genetics 发表时间晚一个月的 in oncology 早收录进去了。小心要出幺蛾子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0abe2931453, createdName=chobit39, createdTime=Wed Dec 28 11:12:15 CST 2022, time=2022-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108229, encodeId=90072108229dd, content=请问大家都有几个审稿人啊，我直接有五个，而且都在规定时间内提了意见，我何德何能啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc9f8128107, createdName=好运常伴, createdTime=Sat Dec 31 00:55:37 CST 2022, time=2022-12-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2106370, encodeId=a23f21063e0ca, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：纯生信 经验分享：请问如何修改作者信息？投稿时作者名字写重了，现在系统里没法修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dd52967601, createdName=214751809, createdTime=Fri Dec 16 17:32:15 CST 2022, time=2022-12-16, status=1, ipAttribution=天津)]

2022-07-27 ms5000001280844911

偏重的研究方向：基因
经验分享：一个审稿人拒绝，另一个让小修并且4 4 4 4分，这种是不是修回去也被拒，正常不应该至少两个审稿人同意才可以吗

47 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向：肿瘤;纯生信;基因 经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2110208, encodeId=c01b2110208a0, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投了一篇生信加大量验证的，当时想不开选了国人编辑，果然对国人最狠的就是同胞，直接痛下杀手, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ef12114541, createdName=1891f95b28m, createdTime=Sat Jan 14 16:06:49 CST 2023, time=2023-01-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1235117, encodeId=a67a123511ebb, content=偏重的研究方向：基因 经验分享：一个审稿人拒绝，另一个让小修并且4 4 4 4分，这种是不是修回去也被拒，正常不应该至少两个审稿人同意才可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83675615943, createdName=ms5000001280844911, createdTime=Wed Jul 27 17:53:30 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105246, encodeId=8cb42105246d8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：阿尔兹海默症 经验分享：投稿一篇纯生信，单基因 六月份投的，很快邀请了一个审稿人，审稿人也很快回复了，提了几个小问题 之后拖了俩月问让推荐审稿人，后来第二个是自己推荐的 前几天accept了，总体来说还是好中的，毕竟我只是个本科菜鸡，希望别预警, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b47b6157206, createdName=ms7000000033418611, createdTime=Sat Dec 10 15:19:57 CST 2022, time=2022-12-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=997387, encodeId=339499e3872c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基因 ; 分子生物学 经验分享：请问有最近5月或者6月投的送外审的嘛？我半个月了，还在编辑手里。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66555211329, createdName=1475e5bfm86暂无昵称, createdTime=Thu Jul 08 06:00:59 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057883, encodeId=c35f105e8835b, content=请问8月9月投稿的同学们，最近从 Editorial assignment到Independent review的时间长吗? 我的20天了还没有动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3a05219761, createdName=黄悦子, createdTime=Tue Oct 05 12:59:36 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208985, encodeId=044d1208985fe, content=从frontiers in pharmacology转投的这个杂志。不知道要多长时间才能到编辑手里呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26f5278477, createdName=14839f7dm82(暂无昵称), createdTime=Wed Apr 06 14:45:58 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107795, encodeId=6694210e7955e, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：wos里面收录的文章大家看看时间把从3 4 月份以后就没收录进去了。而我的另外一篇比我genetics 发表时间晚一个月的 in oncology 早收录进去了。小心要出幺蛾子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0abe2931453, createdName=chobit39, createdTime=Wed Dec 28 11:12:15 CST 2022, time=2022-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108229, encodeId=90072108229dd, content=请问大家都有几个审稿人啊，我直接有五个，而且都在规定时间内提了意见，我何德何能啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc9f8128107, createdName=好运常伴, createdTime=Sat Dec 31 00:55:37 CST 2022, time=2022-12-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2106370, encodeId=a23f21063e0ca, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：纯生信 经验分享：请问如何修改作者信息？投稿时作者名字写重了，现在系统里没法修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dd52967601, createdName=214751809, createdTime=Fri Dec 16 17:32:15 CST 2022, time=2022-12-16, status=1, ipAttribution=天津)]

2022-12-10 ms7000000033418611 来自吉林省

审稿速度:3.0 | 投稿命中率:95.0
偏重的研究方向：阿尔兹海默症
经验分享：投稿一篇纯生信，单基因
六月份投的，很快邀请了一个审稿人，审稿人也很快回复了，提了几个小问题
之后拖了俩月问让推荐审稿人，后来第二个是自己推荐的
前几天accept了，总体来说还是好中的，毕竟我只是个本科菜鸡，希望别预警

52 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向：肿瘤;纯生信;基因 经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2110208, encodeId=c01b2110208a0, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投了一篇生信加大量验证的，当时想不开选了国人编辑，果然对国人最狠的就是同胞，直接痛下杀手, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ef12114541, createdName=1891f95b28m, createdTime=Sat Jan 14 16:06:49 CST 2023, time=2023-01-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1235117, encodeId=a67a123511ebb, content=偏重的研究方向：基因 经验分享：一个审稿人拒绝，另一个让小修并且4 4 4 4分，这种是不是修回去也被拒，正常不应该至少两个审稿人同意才可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83675615943, createdName=ms5000001280844911, createdTime=Wed Jul 27 17:53:30 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105246, encodeId=8cb42105246d8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：阿尔兹海默症 经验分享：投稿一篇纯生信，单基因 六月份投的，很快邀请了一个审稿人，审稿人也很快回复了，提了几个小问题 之后拖了俩月问让推荐审稿人，后来第二个是自己推荐的 前几天accept了，总体来说还是好中的，毕竟我只是个本科菜鸡，希望别预警, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b47b6157206, createdName=ms7000000033418611, createdTime=Sat Dec 10 15:19:57 CST 2022, time=2022-12-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=997387, encodeId=339499e3872c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基因 ; 分子生物学 经验分享：请问有最近5月或者6月投的送外审的嘛？我半个月了，还在编辑手里。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66555211329, createdName=1475e5bfm86暂无昵称, createdTime=Thu Jul 08 06:00:59 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057883, encodeId=c35f105e8835b, content=请问8月9月投稿的同学们，最近从 Editorial assignment到Independent review的时间长吗? 我的20天了还没有动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3a05219761, createdName=黄悦子, createdTime=Tue Oct 05 12:59:36 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208985, encodeId=044d1208985fe, content=从frontiers in pharmacology转投的这个杂志。不知道要多长时间才能到编辑手里呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26f5278477, createdName=14839f7dm82(暂无昵称), createdTime=Wed Apr 06 14:45:58 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107795, encodeId=6694210e7955e, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：wos里面收录的文章大家看看时间把从3 4 月份以后就没收录进去了。而我的另外一篇比我genetics 发表时间晚一个月的 in oncology 早收录进去了。小心要出幺蛾子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0abe2931453, createdName=chobit39, createdTime=Wed Dec 28 11:12:15 CST 2022, time=2022-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108229, encodeId=90072108229dd, content=请问大家都有几个审稿人啊，我直接有五个，而且都在规定时间内提了意见，我何德何能啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc9f8128107, createdName=好运常伴, createdTime=Sat Dec 31 00:55:37 CST 2022, time=2022-12-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2106370, encodeId=a23f21063e0ca, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：纯生信 经验分享：请问如何修改作者信息？投稿时作者名字写重了，现在系统里没法修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dd52967601, createdName=214751809, createdTime=Fri Dec 16 17:32:15 CST 2022, time=2022-12-16, status=1, ipAttribution=天津)]

2021-07-08 1475e5bfm86暂无昵称

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：基因 ; 分子生物学
经验分享：请问有最近5月或者6月投的送外审的嘛？我半个月了，还在编辑手里。

80 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向：肿瘤;纯生信;基因 经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2110208, encodeId=c01b2110208a0, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投了一篇生信加大量验证的，当时想不开选了国人编辑，果然对国人最狠的就是同胞，直接痛下杀手, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ef12114541, createdName=1891f95b28m, createdTime=Sat Jan 14 16:06:49 CST 2023, time=2023-01-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1235117, encodeId=a67a123511ebb, content=偏重的研究方向：基因 经验分享：一个审稿人拒绝，另一个让小修并且4 4 4 4分，这种是不是修回去也被拒，正常不应该至少两个审稿人同意才可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83675615943, createdName=ms5000001280844911, createdTime=Wed Jul 27 17:53:30 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105246, encodeId=8cb42105246d8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：阿尔兹海默症 经验分享：投稿一篇纯生信，单基因 六月份投的，很快邀请了一个审稿人，审稿人也很快回复了，提了几个小问题 之后拖了俩月问让推荐审稿人，后来第二个是自己推荐的 前几天accept了，总体来说还是好中的，毕竟我只是个本科菜鸡，希望别预警, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b47b6157206, createdName=ms7000000033418611, createdTime=Sat Dec 10 15:19:57 CST 2022, time=2022-12-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=997387, encodeId=339499e3872c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基因 ; 分子生物学 经验分享：请问有最近5月或者6月投的送外审的嘛？我半个月了，还在编辑手里。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66555211329, createdName=1475e5bfm86暂无昵称, createdTime=Thu Jul 08 06:00:59 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057883, encodeId=c35f105e8835b, content=请问8月9月投稿的同学们，最近从 Editorial assignment到Independent review的时间长吗? 我的20天了还没有动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3a05219761, createdName=黄悦子, createdTime=Tue Oct 05 12:59:36 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208985, encodeId=044d1208985fe, content=从frontiers in pharmacology转投的这个杂志。不知道要多长时间才能到编辑手里呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26f5278477, createdName=14839f7dm82(暂无昵称), createdTime=Wed Apr 06 14:45:58 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107795, encodeId=6694210e7955e, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：wos里面收录的文章大家看看时间把从3 4 月份以后就没收录进去了。而我的另外一篇比我genetics 发表时间晚一个月的 in oncology 早收录进去了。小心要出幺蛾子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0abe2931453, createdName=chobit39, createdTime=Wed Dec 28 11:12:15 CST 2022, time=2022-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108229, encodeId=90072108229dd, content=请问大家都有几个审稿人啊，我直接有五个，而且都在规定时间内提了意见，我何德何能啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc9f8128107, createdName=好运常伴, createdTime=Sat Dec 31 00:55:37 CST 2022, time=2022-12-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2106370, encodeId=a23f21063e0ca, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：纯生信 经验分享：请问如何修改作者信息？投稿时作者名字写重了，现在系统里没法修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dd52967601, createdName=214751809, createdTime=Fri Dec 16 17:32:15 CST 2022, time=2022-12-16, status=1, ipAttribution=天津)]

2021-10-05 黄悦子

请问8月9月投稿的同学们，最近从 Editorial assignment到Independent review的时间长吗? 我的20天了还没有动静

44 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向：肿瘤;纯生信;基因 经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2110208, encodeId=c01b2110208a0, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投了一篇生信加大量验证的，当时想不开选了国人编辑，果然对国人最狠的就是同胞，直接痛下杀手, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ef12114541, createdName=1891f95b28m, createdTime=Sat Jan 14 16:06:49 CST 2023, time=2023-01-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1235117, encodeId=a67a123511ebb, content=偏重的研究方向：基因 经验分享：一个审稿人拒绝，另一个让小修并且4 4 4 4分，这种是不是修回去也被拒，正常不应该至少两个审稿人同意才可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83675615943, createdName=ms5000001280844911, createdTime=Wed Jul 27 17:53:30 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105246, encodeId=8cb42105246d8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：阿尔兹海默症 经验分享：投稿一篇纯生信，单基因 六月份投的，很快邀请了一个审稿人，审稿人也很快回复了，提了几个小问题 之后拖了俩月问让推荐审稿人，后来第二个是自己推荐的 前几天accept了，总体来说还是好中的，毕竟我只是个本科菜鸡，希望别预警, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b47b6157206, createdName=ms7000000033418611, createdTime=Sat Dec 10 15:19:57 CST 2022, time=2022-12-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=997387, encodeId=339499e3872c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基因 ; 分子生物学 经验分享：请问有最近5月或者6月投的送外审的嘛？我半个月了，还在编辑手里。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66555211329, createdName=1475e5bfm86暂无昵称, createdTime=Thu Jul 08 06:00:59 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057883, encodeId=c35f105e8835b, content=请问8月9月投稿的同学们，最近从 Editorial assignment到Independent review的时间长吗? 我的20天了还没有动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3a05219761, createdName=黄悦子, createdTime=Tue Oct 05 12:59:36 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208985, encodeId=044d1208985fe, content=从frontiers in pharmacology转投的这个杂志。不知道要多长时间才能到编辑手里呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26f5278477, createdName=14839f7dm82(暂无昵称), createdTime=Wed Apr 06 14:45:58 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107795, encodeId=6694210e7955e, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：wos里面收录的文章大家看看时间把从3 4 月份以后就没收录进去了。而我的另外一篇比我genetics 发表时间晚一个月的 in oncology 早收录进去了。小心要出幺蛾子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0abe2931453, createdName=chobit39, createdTime=Wed Dec 28 11:12:15 CST 2022, time=2022-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108229, encodeId=90072108229dd, content=请问大家都有几个审稿人啊，我直接有五个，而且都在规定时间内提了意见，我何德何能啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc9f8128107, createdName=好运常伴, createdTime=Sat Dec 31 00:55:37 CST 2022, time=2022-12-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2106370, encodeId=a23f21063e0ca, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：纯生信 经验分享：请问如何修改作者信息？投稿时作者名字写重了，现在系统里没法修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dd52967601, createdName=214751809, createdTime=Fri Dec 16 17:32:15 CST 2022, time=2022-12-16, status=1, ipAttribution=天津)]

2022-04-06 14839f7dm82(暂无昵称)

从frontiers in pharmacology转投的这个杂志。不知道要多长时间才能到编辑手里呢

45 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向：肿瘤;纯生信;基因 经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2110208, encodeId=c01b2110208a0, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投了一篇生信加大量验证的，当时想不开选了国人编辑，果然对国人最狠的就是同胞，直接痛下杀手, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ef12114541, createdName=1891f95b28m, createdTime=Sat Jan 14 16:06:49 CST 2023, time=2023-01-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1235117, encodeId=a67a123511ebb, content=偏重的研究方向：基因 经验分享：一个审稿人拒绝，另一个让小修并且4 4 4 4分，这种是不是修回去也被拒，正常不应该至少两个审稿人同意才可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83675615943, createdName=ms5000001280844911, createdTime=Wed Jul 27 17:53:30 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105246, encodeId=8cb42105246d8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：阿尔兹海默症 经验分享：投稿一篇纯生信，单基因 六月份投的，很快邀请了一个审稿人，审稿人也很快回复了，提了几个小问题 之后拖了俩月问让推荐审稿人，后来第二个是自己推荐的 前几天accept了，总体来说还是好中的，毕竟我只是个本科菜鸡，希望别预警, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b47b6157206, createdName=ms7000000033418611, createdTime=Sat Dec 10 15:19:57 CST 2022, time=2022-12-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=997387, encodeId=339499e3872c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基因 ; 分子生物学 经验分享：请问有最近5月或者6月投的送外审的嘛？我半个月了，还在编辑手里。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66555211329, createdName=1475e5bfm86暂无昵称, createdTime=Thu Jul 08 06:00:59 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057883, encodeId=c35f105e8835b, content=请问8月9月投稿的同学们，最近从 Editorial assignment到Independent review的时间长吗? 我的20天了还没有动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3a05219761, createdName=黄悦子, createdTime=Tue Oct 05 12:59:36 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208985, encodeId=044d1208985fe, content=从frontiers in pharmacology转投的这个杂志。不知道要多长时间才能到编辑手里呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26f5278477, createdName=14839f7dm82(暂无昵称), createdTime=Wed Apr 06 14:45:58 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107795, encodeId=6694210e7955e, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：wos里面收录的文章大家看看时间把从3 4 月份以后就没收录进去了。而我的另外一篇比我genetics 发表时间晚一个月的 in oncology 早收录进去了。小心要出幺蛾子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0abe2931453, createdName=chobit39, createdTime=Wed Dec 28 11:12:15 CST 2022, time=2022-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108229, encodeId=90072108229dd, content=请问大家都有几个审稿人啊，我直接有五个，而且都在规定时间内提了意见，我何德何能啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc9f8128107, createdName=好运常伴, createdTime=Sat Dec 31 00:55:37 CST 2022, time=2022-12-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2106370, encodeId=a23f21063e0ca, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：纯生信 经验分享：请问如何修改作者信息？投稿时作者名字写重了，现在系统里没法修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dd52967601, createdName=214751809, createdTime=Fri Dec 16 17:32:15 CST 2022, time=2022-12-16, status=1, ipAttribution=天津)]

2022-12-28 chobit39 来自上海

审稿速度:2.0
偏重的研究方向：肿瘤
经验分享：wos里面收录的文章大家看看时间把从3 4 月份以后就没收录进去了。而我的另外一篇比我genetics 发表时间晚一个月的 in oncology 早收录进去了。小心要出幺蛾子

33 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向：肿瘤;纯生信;基因 经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2110208, encodeId=c01b2110208a0, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投了一篇生信加大量验证的，当时想不开选了国人编辑，果然对国人最狠的就是同胞，直接痛下杀手, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ef12114541, createdName=1891f95b28m, createdTime=Sat Jan 14 16:06:49 CST 2023, time=2023-01-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1235117, encodeId=a67a123511ebb, content=偏重的研究方向：基因 经验分享：一个审稿人拒绝，另一个让小修并且4 4 4 4分，这种是不是修回去也被拒，正常不应该至少两个审稿人同意才可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83675615943, createdName=ms5000001280844911, createdTime=Wed Jul 27 17:53:30 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105246, encodeId=8cb42105246d8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：阿尔兹海默症 经验分享：投稿一篇纯生信，单基因 六月份投的，很快邀请了一个审稿人，审稿人也很快回复了，提了几个小问题 之后拖了俩月问让推荐审稿人，后来第二个是自己推荐的 前几天accept了，总体来说还是好中的，毕竟我只是个本科菜鸡，希望别预警, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b47b6157206, createdName=ms7000000033418611, createdTime=Sat Dec 10 15:19:57 CST 2022, time=2022-12-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=997387, encodeId=339499e3872c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基因 ; 分子生物学 经验分享：请问有最近5月或者6月投的送外审的嘛？我半个月了，还在编辑手里。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66555211329, createdName=1475e5bfm86暂无昵称, createdTime=Thu Jul 08 06:00:59 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057883, encodeId=c35f105e8835b, content=请问8月9月投稿的同学们，最近从 Editorial assignment到Independent review的时间长吗? 我的20天了还没有动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3a05219761, createdName=黄悦子, createdTime=Tue Oct 05 12:59:36 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208985, encodeId=044d1208985fe, content=从frontiers in pharmacology转投的这个杂志。不知道要多长时间才能到编辑手里呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26f5278477, createdName=14839f7dm82(暂无昵称), createdTime=Wed Apr 06 14:45:58 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107795, encodeId=6694210e7955e, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：wos里面收录的文章大家看看时间把从3 4 月份以后就没收录进去了。而我的另外一篇比我genetics 发表时间晚一个月的 in oncology 早收录进去了。小心要出幺蛾子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0abe2931453, createdName=chobit39, createdTime=Wed Dec 28 11:12:15 CST 2022, time=2022-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108229, encodeId=90072108229dd, content=请问大家都有几个审稿人啊，我直接有五个，而且都在规定时间内提了意见，我何德何能啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc9f8128107, createdName=好运常伴, createdTime=Sat Dec 31 00:55:37 CST 2022, time=2022-12-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2106370, encodeId=a23f21063e0ca, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：纯生信 经验分享：请问如何修改作者信息？投稿时作者名字写重了，现在系统里没法修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dd52967601, createdName=214751809, createdTime=Fri Dec 16 17:32:15 CST 2022, time=2022-12-16, status=1, ipAttribution=天津)]

2022-12-31 好运常伴来自山西省

请问大家都有几个审稿人啊，我直接有五个，而且都在规定时间内提了意见，我何德何能啊

46 0

[GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向：肿瘤;纯生信;基因 经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2110208, encodeId=c01b2110208a0, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投了一篇生信加大量验证的，当时想不开选了国人编辑，果然对国人最狠的就是同胞，直接痛下杀手, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ef12114541, createdName=1891f95b28m, createdTime=Sat Jan 14 16:06:49 CST 2023, time=2023-01-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1235117, encodeId=a67a123511ebb, content=偏重的研究方向：基因 经验分享：一个审稿人拒绝，另一个让小修并且4 4 4 4分，这种是不是修回去也被拒，正常不应该至少两个审稿人同意才可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83675615943, createdName=ms5000001280844911, createdTime=Wed Jul 27 17:53:30 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105246, encodeId=8cb42105246d8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：阿尔兹海默症 经验分享：投稿一篇纯生信，单基因 六月份投的，很快邀请了一个审稿人，审稿人也很快回复了，提了几个小问题 之后拖了俩月问让推荐审稿人，后来第二个是自己推荐的 前几天accept了，总体来说还是好中的，毕竟我只是个本科菜鸡，希望别预警, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b47b6157206, createdName=ms7000000033418611, createdTime=Sat Dec 10 15:19:57 CST 2022, time=2022-12-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=997387, encodeId=339499e3872c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基因 ; 分子生物学 经验分享：请问有最近5月或者6月投的送外审的嘛？我半个月了，还在编辑手里。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66555211329, createdName=1475e5bfm86暂无昵称, createdTime=Thu Jul 08 06:00:59 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057883, encodeId=c35f105e8835b, content=请问8月9月投稿的同学们，最近从 Editorial assignment到Independent review的时间长吗? 我的20天了还没有动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3a05219761, createdName=黄悦子, createdTime=Tue Oct 05 12:59:36 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208985, encodeId=044d1208985fe, content=从frontiers in pharmacology转投的这个杂志。不知道要多长时间才能到编辑手里呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26f5278477, createdName=14839f7dm82(暂无昵称), createdTime=Wed Apr 06 14:45:58 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107795, encodeId=6694210e7955e, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：wos里面收录的文章大家看看时间把从3 4 月份以后就没收录进去了。而我的另外一篇比我genetics 发表时间晚一个月的 in oncology 早收录进去了。小心要出幺蛾子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0abe2931453, createdName=chobit39, createdTime=Wed Dec 28 11:12:15 CST 2022, time=2022-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108229, encodeId=90072108229dd, content=请问大家都有几个审稿人啊，我直接有五个，而且都在规定时间内提了意见，我何德何能啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc9f8128107, createdName=好运常伴, createdTime=Sat Dec 31 00:55:37 CST 2022, time=2022-12-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2106370, encodeId=a23f21063e0ca, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：纯生信 经验分享：请问如何修改作者信息？投稿时作者名字写重了，现在系统里没法修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dd52967601, createdName=214751809, createdTime=Fri Dec 16 17:32:15 CST 2022, time=2022-12-16, status=1, ipAttribution=天津)]

2022-12-16 214751809 来自天津

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：纯生信
经验分享：请问如何修改作者信息？投稿时作者名字写重了，现在系统里没法修改

39 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务